Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Capecitabine in Advanced Biliary Tract Cancer
NCT00033540Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2003
- Primary completion
- Apr 2008
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, gemcitabine in gallbladder cancer, cholangiocarcinoma (CCA), sponsored by SWOG Cancer Research Network. Started Sep 2003; status: completed.
02
Drugs
capecitabinegemcitabine
03
Conditions
gallbladder cancercholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00033540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033540.